Literature DB >> 24211637

Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors.

Ronggui Guan1, Xiaoyu Xu, Meihui Chen, Haiyan Hu, Hu Ge, Shijun Wen, Shiyou Zhou, Rongbiao Pi.   

Abstract

RhoA/Rho-kinase pathway plays a pivotal role in numerous fundamental cellular functions including contraction, motility, proliferation, differentiation and apoptosis. The pathway is also involved in the development of many diseases such as vasospasm, pulmonary hypertension, cancer and central nervous systems (CNS) disorders. The inhibitors of Rho kinase have been extensively studied since the Rho/Rho-kinase pathway was verified as a target for a number of diseases. Herein, we reviewed the advances in the studies of the roles of Rho/Rho-kinase in diseases and the development of Rho-kinase inhibitors in recent five years.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  5-HT; 5-hydroxytryptamine; ACS; AP-1; AT1; C-terminal cysteine-rich domain; CNS; CPI-17; CPK; CRD; CRMP-2; Central nervous system; DMPK; ERK; ERM; ET-1; Fasudil; GAPs; GDIs; GDP dissociation inhibitors; GEFs; GTPase-activating proteins; HCC; IP3; Inhibitors; LDH; MCP-1; MEK; MES; MLC; MRCK; MYPT-1; NLSs; OpN; PAH; PAI-1; PH; PKC-potentiated inhibitory protein 17; PTEN; PTZ; RBD; ROCK; Rho kinase; Rho-binding domain; Rho-kinase; RhoA; UPS; VA; VCAM-1; VSMC; activator protein-1; acute coronary syndrome; angiotensin II type 1 receptor; central nervous system; collapsin response mediator protein 2; creatine phosphokinase; endothelin-1; extracellular signal-regulated kinase; ezrin/radixin/moesin family; guanine nucleotide exchange factors; hepatocellular carcinoma; inositol 1,4,5-trisphosphate; lactate dehydrogenase; maximal electroconvulsive shock; mitogen-activated protein kinase; monocyte chemoattractant protein-1; myosin light chain; myosin phosphatase target subunit 1; myotonic dystrophy kinase; myotonic dystrophy kinase-related CDC42-binding kinase; nuclear localization signals; optic nerve; pentylenetetrazole; phosphatase and tensin homolog deleted on chromosome 10; plasminogen activator inhibitor-1; pleckstrin homology; pulmonary arterial hypertension; ubiquitin–proteasome system; vascular cell adhesion molecule-1; vascular smooth muscle cell; vasospastic angina

Mesh:

Substances:

Year:  2013        PMID: 24211637     DOI: 10.1016/j.ejmech.2013.10.048

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  32 in total

1.  Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.

Authors:  Changhwan Yoon; Soo-Jeong Cho; Bülent Arman Aksoy; Do Joong Park; Nikolaus Schultz; Sandra W Ryeom; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

Review 2.  Discovery of Molecular Therapeutics for Glaucoma: Challenges, Successes, and Promising Directions.

Authors:  Rebecca K Donegan; Raquel L Lieberman
Journal:  J Med Chem       Date:  2015-09-25       Impact factor: 7.446

3.  Discovery of vascular Rho kinase (ROCK) inhibitory peptides.

Authors:  Reza Abbasgholizadeh; Hua Zhang; John W Craft; Robert M Bryan; Steven J Bark; James M Briggs; Robert O Fox; Anton Agarkov; Warren E Zimmer; Scott R Gilbertson; Robert J Schwartz
Journal:  Exp Biol Med (Maywood)       Date:  2019-05-27

Review 4.  Rho kinase as a target for cerebral vascular disorders.

Authors:  Lisa M Bond; James R Sellers; Lisa McKerracher
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

5.  Effect of fasudil on hypoxic pulmonary hypertension and right ventricular hypertrophy in rats.

Authors:  Xing-Zhen Sun; Shu-Yan Li; Xiang-Yang Tian; Qing-Quan Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

6.  Role of Rac1 Pathway in Epithelial-to-Mesenchymal Transition and Cancer Stem-like Cell Phenotypes in Gastric Adenocarcinoma.

Authors:  Changhwan Yoon; Soo-Jeong Cho; Kevin K Chang; Do Joong Park; Sandra W Ryeom; Sam S Yoon
Journal:  Mol Cancer Res       Date:  2017-05-01       Impact factor: 5.852

7.  Cell permeable peptide conjugated nanoerythrosomes of fasudil prolong pulmonary arterial vasodilation in PAH rats.

Authors:  Nilesh Gupta; Brijeshkumar Patel; Kamrun Nahar; Fakhrul Ahsan
Journal:  Eur J Pharm Biopharm       Date:  2014-11       Impact factor: 5.571

8.  Withdrawal from repeated morphine administration augments expression of the RhoA network in the nucleus accumbens to control synaptic structure.

Authors:  Michael E Cahill; Caleb J Browne; Junshi Wang; Peter J Hamilton; Yan Dong; Eric J Nestler
Journal:  J Neurochem       Date:  2018-09-26       Impact factor: 5.372

9.  Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma.

Authors:  Kevin K Chang; Soo-Jeong Cho; Changhwan Yoon; Jun Ho Lee; Do Joong Park; Sam S Yoon
Journal:  Ann Surg Oncol       Date:  2016-06-30       Impact factor: 5.344

10.  Leiomyoma cells in 3-dimensional cultures demonstrate an attenuated response to fasudil, a rho-kinase inhibitor, when compared to 2-dimensional cultures.

Authors:  Minnie Malik; Joy Britten; James Segars; William H Catherino
Journal:  Reprod Sci       Date:  2014-08-01       Impact factor: 3.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.